Cutter Capital Management’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-379,303
Closed -$13.7M 14
2025
Q1
$13.7M Sell
379,303
-27,500
-7% -$996K 5.98% 6
2024
Q4
$17.1M Buy
406,803
+120,000
+42% +$5.05M 7.01% 5
2024
Q3
$15.9M Sell
286,803
-78,197
-21% -$4.34M 4.7% 5
2024
Q2
$15M Buy
+365,000
New +$15M 4.53% 10